Table of Contents
Research Article
Deprescribing Has Been Shown to Be Possible, Not Yet to Be Beneficial: A Critical Review of the Trial Evidence
Dr. Priyadharshini P.
pp. 1-9 Sep 1, 2026
Deprescribing; Polypharmacy, Older Adults, Potentially Inappropriate Medication, Antihypertensives, Evidence Appraisal.
Research Article
What an Interaction can Possibly Be: The Fraction-Metabolised Ceiling and the Limits of Categorical Drug Interaction Severity Labels
Dr. Makbul Hussain Choudhury
pp. 10-20 Sep 1, 2026
Drug Interactions, Cytochrome P450; Fraction Metabolised, Static Mechanistic Model, Clinical Decision Support, Alert Fatigue.
Research Article
Drug Forgiveness is about Depth, not Duration: A Pharmacokinetic Simulation of Missed Doses across Half-Lives
Abdul Mukit
pp. 21-29 Sep 1, 2026
Adherence, Drug Forgiveness, Pharmacokinetics, Half-Life, Missed Doses, Simulation.
Research Article
Why the Trough Target Over-Doses: A Population Pharmacokinetic Simulation of Trough-Guided against AUC-Guided Vancomycin Dosing
Dr. Ayesha Sara
pp. 30-39 Sep 1, 2026
Vancomycin, Therapeutic Drug Monitoring, Pharmacokinetics, Auc-Guided Dosing, Nephrotoxicity, Monte Carlo Simulation.
Research Article
How much Excess Treatment Failure can a Shorter Antibiotic Course Afford? A Net-Benefit Analysis of Duration Shortening
Dr. Mosrur Ahmed
pp. 40-48 Sep 1, 2026
Antibiotic Duration, Non-Inferiority, Net Benefit, Decision Analysis, Antimicrobial Stewardship, Treatment Failure.